| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |